07/30/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
8:55 AM | ACORN BIOVENTURES, L.P. (Filed by)
Candel Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CADL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/26/2025
7:30 AM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:30 PM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
8:20 AM | Candel Therapeutics (Filer)
| Form 424B5 | |
06/24/2025
8:27 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
7:32 AM | Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:33 AM | Candel Therapeutics (Issuer)
Nguyen Diem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:33 AM | Candel Therapeutics (Issuer)
Nabel Gary J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:34 AM | Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:35 AM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:36 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:37 AM | Candel Therapeutics (Issuer)
Gaeta Renee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
7:38 AM | Benz Edward J. JR (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:31 PM | Candel Therapeutics (Issuer)
Radhakrishnan Maha (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
7:11 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
7:10 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2025
4:12 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:15 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
8:57 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
3:35 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4/A | |
03/20/2025
3:35 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:36 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:36 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:12 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:28 PM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
3:29 PM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
3:29 PM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
03/17/2025
3:29 PM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
3:29 PM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
3:45 PM | Candel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025
12:35 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:32 PM | Candel Therapeutics (Subject)
Northpond Ventures, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
3:30 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:25 AM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:09 PM | Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:18 AM | Candel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:03 AM | Candel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
7:05 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:27 AM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:27 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:28 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:28 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:29 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024
6:37 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
12:59 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:11 PM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
11:30 AM | Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G | |
12/13/2024
5:12 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:30 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
3:36 PM | Candel Therapeutics (Filer)
| Form 424B5 | |
12/12/2024
3:55 PM | Candel Therapeutics (Filer)
| Form 424B5 | |
12/11/2024
6:45 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
5:44 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:46 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:47 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:48 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:48 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
8:12 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:13 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:15 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:17 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
5:24 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump set to Boost Social Security Checks by 400%? (Ad) If you're collecting or planning to collect social security...
You should see this presentation about President Trump's Executive Order #14196.
Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse...
But BOOST benefits for millions of retirees by up to 400%.
No wonder the financial times called this new initiative... Click here to see the details because the stakes couldn't be any higher. |
11/21/2024
2:07 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:58 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
5:08 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
5:41 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:59 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:19 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
